Thyroid Diseases
94
18
20
45
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.1%
2 terminated out of 94 trials
95.7%
+9.2% vs benchmark
11%
10 trials in Phase 3/4
11%
5 of 45 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 45 completed trials
Clinical Trials (94)
The Effect of Mobile-Based Education on Postoperative Recovery and Quality of Life in Thyroidectomy Patients
Effectiveness of WeChat-Supported Neck Rehabilitation Exercises on Early Recovery After Thyroidectomy
Oxidized Regenerated Cellulose and Voice Quality After Total Thyroidectomy
Postoperative Pain of Robotic, Endoscopic and Open Lateral Neck Dissection
Effects of Different Administration Routes of Dexmedetomidine on Postoperative Sleep Quality in Patients Undergoing Thyroidectomy
Computer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal Nerves in Endoscopic Surgery
NIRAF-Guided Parathyroid Identification During Thyroidectomy
Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) Protocol
Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery
Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
Safety and Efficacy of NTP in Thyroid Surgery: Pilot Study on Morbidity Prevention and Adjuvant Oncological Control
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
Prospective Evaluation of OptiThyDose
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC